Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph III Tabelecleucel for Subjects w/ Epstein-Barr Virus- (ALLELE Study)

Protocol: OSU-18035

Full Title

Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study)

Sarcoma Lymphoma Non-Hodgkin’s Lymphoma (B- & T-Cell)